e.g. Tata motors, Reliance MF, 500570

Fresenius Kabi Oncology Ltd.

 FKONCO   Group (B)

02 Jan,15:51
132.3 0.20 (0.15%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
    Download App
BSE
zoomZoomRefresh
Day
Wk
Mn
6Mn
Yr
Volume

91,518

Prev close

132.10

Day's H/L (Rs.)

132.60 - 132.00

52wk H/L (Rs.)

161.40 - 93.10

Mkt Cap (Rs. Cr)

2,093.36

Fresenius Kabi Oncology Ltd.

InvestChart

is not listed on NSE (View BSE)

Financial Results of Fresenius Kabi Oncology Ltd.

(Rs. Crore)
Mar ' 13Mar ' 12Mar ' 11Mar ' 10Mar ' 09
Sales596.30524.32412.37421.48286.29
Operating profit143.0067.4595.9896.64-29.29
Interest-2.6013.0718.0319.4021.97
Gross profit147.4055.7784.2483.38-51.26
EPS (Rs)5.093.223.115.07-4.91

See More >

Compare 'Fresenius Kabi Oncology Ltd.' with other stocks

  • Sai Life Science Ltd.
  • 1,112.65
  • Compare
  • Sun Pharmaceutical Industries Ltd.
  • 1,845.20
  • Compare
  • Divi's Laboratories Ltd.
  • 6,885.00
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 1,307.10
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 4,484.15
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,038.95
  • Compare
  • Max Healthcare Institute Ltd.
  • 1,023.25
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 8,359.75
  • Compare

Statements:

Balance Sheet  |  P&L  |  Cash Flow  |  Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

Fresenius Kabi Oncology Ltd. PERFORMANCE SNAPSHOT

If you had invested Rs.
in Fresenius Kabi Oncology Ltd.,
  ago

You would have Rs. 000.00

Add to Portfolio

Report Card

PE Ratios
EPS (Rs.)
5.09
Sales (Rs. Cr)
84.66
Face Value (Rs.)
1
Net Profit Margin (%)
13.47
Last Bonus
Last Dividend (%)
20
Return on Average Equity
11.97

Frequently Asked Questions

Q: What is the current share price of Fresenius Kabi Oncology Ltd.?

A: The current share price of Fresenius Kabi Oncology Ltd. is ₹ 132.3 (for BSE as on 02 Jan,15:51). The 52-week range is ₹ 161.40 - 93.10. Prices are updated based on live market data.

Q: What is the market capitalization of Fresenius Kabi Oncology Ltd.?

A: Fresenius Kabi Oncology Ltd. has a market capitalization of ₹ 2,093.36 Cr, making it a company.

Q: What is the PE ratio of Fresenius Kabi Oncology Ltd.?

A: The Price-to-Earnings (PE) ratio of Fresenius Kabi Oncology Ltd. is , indicating its valuation relative to earnings.

Q: Is Fresenius Kabi Oncology Ltd. a good investment?

A: Fresenius Kabi Oncology Ltd. is considered based on its financial performance, sector outlook, and market conditions. Investors should evaluate fundamentals and consult financial advisors before investing.

Q: Does Fresenius Kabi Oncology Ltd. pay dividends?

A: Yes. Fresenius Kabi Oncology Ltd. pay dividends. The latest dividend yield is 20%.

Q: What are the latest financial results of Fresenius Kabi Oncology Ltd.?

A: Fresenius Kabi Oncology Ltd. has reported its latest annual results with revenue of ₹ 596.30 and net profit/loss of ₹ 80.59.

Close
Add Fresenius Kabi Oncology Ltd. to your Portfolio
 
 
     
 
Close
Add Fresenius Kabi Oncology Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback